The idea that you can "catch" shingles is one of the more common misconceptions I hear from patients who arrive worried ...

The China National Medical Products Administration (NMPA) has approved Shingrix (GSK's Recombinant Zoster Vaccine or RZV) for ...

Vielot and her colleagues found that among 3.45 million people evaluated across 12 emulated trials in analysis 1, the one-year vaccine effectiveness of at least one Shingrix dose was 56.1% against any ...

New research reveals many Australians over 50 underestimate their shingles risk. Learn the signs, symptoms and how to protect ...

CNW/ - Results from a new retrospective study (VEO-000477) adds to research uncovering a relationship between cardiovascular ...

Prefilled syringe offers a convenient ready-to-use administration option to healthcare professionals·        Marketing authorisation in EU expected in December ...

The shingles vaccine not only protects against the painful skin infection, but also might provide heart health benefits, a new study says. Shingles vaccination also appears to lower a person's risk of ...

EMA committee issues positive opinion to support the approval of GSK’s recombinant zoster vaccine, Shingrix in a prefilled syringe: London, UK Wednesday, October 22, 2025, 16:00 ...

China NMPA approves GSK’s Shingrix for prevention of shingles in adults aged 18 and over who are at increased risk due to immunodeficiency or immunosuppression: London, UK Wedne ...